New Study Highlights Promising Results in Cancer Treatment
Research reveals that over 500 cancer survivor participants found success with the medicinal use of cannabis

By Sechat editorial team with information from Hightimes
A recently published study in the Journal of Cancer Survivorship sheds light on the positive impact of cannabis use in treating cancer survivor patients. Funded by American philanthropic institutions such as the National Cancer Institute, Betty B. Marcus Chair in Cancer Prevention, and the Duncan Family Institute for Cancer Prevention and Risk Assessment, the research analyzed 1,886 participants, highlighting that 17.4% of survivors reported current cannabis consumption.
Among the participants who used or had used cannabis (approximately 510), the majority reported significant relief in symptoms such as sleep disturbances (60%), pain (51%), stress (44%), nausea (34%), and mood disorder/depression (32%). Surprisingly, 20% of these participants used cannabis specifically to treat cancer, with half of them experiencing a significant improvement in disease-related symptoms.
However, only 167 participants reported negative side effects, such as suicidal thoughts (5%), severe nausea and vomiting (6%), depression (11%), anxiety (14%), respiratory issues (31%), and interaction with cancer medications (35%).

The results show that globally, half of the participants considered cannabis "very useful," indicating a positive perception regarding its use in disease treatment. When used to treat nausea, for example, 73.6% of participants described the benefits as effective.
In light of these findings, researchers emphasize the need for more studies to strengthen evidence on cannabis therapy. Additionally, they highlight the importance of clear policies, guidelines, and educational programs for healthcare professionals and patients regarding the benefits and risks associated with cannabis use in the cancer context.
The research also revealed that most participants were unaware of potential health risks associated with cannabis consumption during cancer treatment. This underscores the urgency of awareness and dialogue between healthcare professionals and patients regarding treatments involving the plant and its compounds.
As the debate continues, the effectiveness of cannabis in cancer treatment remains under exploration, with recent research showing promising therapeutic alternatives, such as the use of psychedelic substances.
